These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 18479603

  • 1. [Correlations of high-risk human papillomaviral load to cervical intraepithelial neoplasia grades, expression of Ki-67 and P6ink4a and follow-up].
    Yi W, Wang JL, Li XH, Wei LH.
    Ai Zheng; 2008 May; 27(5):520-4. PubMed ID: 18479603
    [Abstract] [Full Text] [Related]

  • 2. The expression of p16 (INK4a) and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins.
    Song SH, Park HM, Eom DW, Lee JK, Lee NW, Kim AR, Hur JY, Lee KW, Park YK, Saw HS.
    Int J Gynecol Cancer; 2007 May; 17(4):858-67. PubMed ID: 17367326
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of p16INK4a and Ki-67 proteins expression in cervical intraepithelial neoplasia and their correlation with HPV-HR infection].
    Ungureanu C, Teleman S, Socolov D, Anton G, Mihailovici MS.
    Rev Med Chir Soc Med Nat Iasi; 2010 May; 114(3):823-8. PubMed ID: 21243810
    [Abstract] [Full Text] [Related]

  • 4. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [Abstract] [Full Text] [Related]

  • 5. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
    Li Y, Liu J, Gong L, Sun X, Long W.
    Virol J; 2019 Oct 16; 16(1):117. PubMed ID: 31619262
    [Abstract] [Full Text] [Related]

  • 6. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.
    Solares C, Velasco J, Álvarez-Ruiz E, González-Fernández L, Encinas AI, Astudillo A, Schneider J.
    Anticancer Res; 2015 Nov 16; 35(11):6291-5. PubMed ID: 26504065
    [Abstract] [Full Text] [Related]

  • 7. High-risk human papillomavirus load and biomarkers in cervical intraepithelial neoplasia and cancer.
    Chang MS, Oh S, Jung EJ, Park JH, Jeon HW, Lee TS, Kim JH, Choi E, Byeon SJ, Park IA.
    APMIS; 2014 May 16; 122(5):427-36. PubMed ID: 24020724
    [Abstract] [Full Text] [Related]

  • 8. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies.
    Nieh S, Chen SF, Chu TY, Lai HC, Lin YS, Fu E, Gau CH.
    Gynecol Oncol; 2005 Apr 16; 97(1):35-40. PubMed ID: 15790434
    [Abstract] [Full Text] [Related]

  • 9. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
    Koo YJ, Hahn HS, Lee IH, Lim KT, Lee KH, Kim HS, Kim TJ, Chun YK, Kim HS, Hong SR.
    Virchows Arch; 2013 Nov 16; 463(5):689-96. PubMed ID: 24081504
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Ovestad IT, Dalen I, Hansen E, Loge JL, Dybdahl BM, Dirdal MB, Moltu P, Berland JM.
    Cancer Cytopathol; 2017 Apr 16; 125(4):283-291. PubMed ID: 27918650
    [Abstract] [Full Text] [Related]

  • 13. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y, Zhao J, Hu J, Wu XW, Zhu LR.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov 25; 52(11):734-739. PubMed ID: 29179267
    [Abstract] [Full Text] [Related]

  • 14. TOP2A/MCM2, p16INK4a, and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions.
    Del Moral-Hernández O, Hernández-Sotelo D, Alarcón-Romero LDC, Mendoza-Catalán MA, Flores-Alfaro E, Castro-Coronel Y, Ortiz-Ortiz J, Leyva-Vázquez MA, Ortuño-Pineda C, Castro-Mora W, Illades-Aguiar B.
    BMC Cancer; 2021 Jan 07; 21(1):39. PubMed ID: 33413211
    [Abstract] [Full Text] [Related]

  • 15. [Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].
    Zhao FH, Hu SY, Wang SM, Chen F, Zhang X, Zhang WH, Pan QJ, Qiao YL.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul 07; 43(7):565-70. PubMed ID: 19954065
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens.
    Yu L, Wang L, Zhong J, Chen S.
    Cancer Cytopathol; 2010 Feb 25; 118(1):47-55. PubMed ID: 20069634
    [Abstract] [Full Text] [Related]

  • 17. Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus.
    Longatto Filho A, Utagawa ML, Shirata NK, Pereira SM, Namiyama GM, Kanamura CT, Santos Gda C, de Oliveira MA, Wakamatsu A, Nonogaki S, Roteli-Martins C, di Loreto C, Mattosinho de Castro Ferraz Mda G, Maeda MY, Alves VA, Syrjänen K.
    Int J Gynecol Pathol; 2005 Apr 25; 24(2):118-24. PubMed ID: 15782067
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
    Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan QJ, Zhang X, Chang BF, Zhang SK, Guo HQ, Qiao YL.
    Oncotarget; 2016 Apr 19; 7(16):21181-9. PubMed ID: 27029033
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.